Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults

Hendrickx S, Vlimmeren KV, Baar I, et al. Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults. Anestezjologia Intensywna Terapia. 2017:377-383.

APA

Hendrickx, S., Vlimmeren, K. V., Baar, I., Verbrugghe, W., Dams, K.,  & Cromphaut, S. V. et al. (2017). Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults. Anestezjologia Intensywna Terapia, 377-383.

Chicago

Hendrickx, Steven, Karen V Vlimmeren, Ingrid Baar, Walter Verbrugghe, Karolien Dams, Sophie V Cromphaut,  and Ella Roelant et al. 2017. "Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults". Anestezjologia Intensywna Terapia: 377-383.

Harvard

Hendrickx, S., Vlimmeren, K., Baar, I., Verbrugghe, W., Dams, K., Cromphaut, S., Roelant, E., Embrecht, B., Wittock, A., Mertens, P., Hendriks, J., Lauwers, P., Schil, P., Craenenbroeck, A., Wyngaert, T., Jorens, P.,  and Regenmortel, N. (2017). Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults. Anestezjologia Intensywna Terapia, pp.377-383.

MLA

Hendrickx, Steven et al. "Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults." Anestezjologia Intensywna Terapia, 2017, pp. 377-383.

Vancouver

Hendrickx S, Vlimmeren K, Baar I, Verbrugghe W, Dams K, Cromphaut S et al. Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults. Anestezjologia Intensywna Terapia. 2017:377-383.

This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.